|
|
Acelyrin Inc (NASDAQ: SLRN) |
|
*Market share is calculated based on total revenue.
News about Acelyrin Inc Contracts |
October 16, 2024
In a significant stride towards advancing the treatment landscape for Thyroid Eye Disease (TED), ACELYRIN, INC. has officially announced the formation of a Scientific and Patient Advisory Board. This coalition is comprised of prominent voices within the realms of clinical research and patient advocacy, who will provide vital strategic input as the company progresses through its Phase 2 clinical trial of lonigutamab, a promising therapeutic candidate for TED. The Need for Expertise in TED Thyroid Eye Disease, commonly associated with Graves disease, is a debilitating condition that can lead to a multitude of complications, including vision loss and cosmetic deformities. As the understanding of TED evolves, t...
|
September 19, 2024
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules, abscesses, and sinus tract formation. The condition can significantly impact patients quality of life due to pain, discomfort, and psychosocial distress. While various treatment options exist, there remains a need for more effective therapeutic agents for moderate-to-severe cases. Recently, Acelyrin, Inc. announced promising results from a Phase 3 clinical trial evaluating izokibep, a novel therapeutic agent, in patients with moderate-to-severe HS. Study Overview and Presentation On September 19, 2024, Acelyrin, Inc. revealed that positive results from their global Phase 3 clinical trial of izokibep will...
|
September 10, 2024
CSIMarket.com Date: 12th October 2023 In a most auspicious development for the field of ophthalmic medicine, ACELYRIN, INC., renowned for its relentless innovation in biopharmaceuticals, hath declared the forthcoming unveiling of promising proof-of-concept data emerging from their Phase 1/2 clinical trial of the novel therapeutic agent Lonigutamab, designed for the subcutaneous treatment of Thyroid Eye Disease (TED). This prestigious information is to be presented at the forthcoming 42nd Annual Meeting of the European Society of Ophthalmic Plastic and Reconstructive Surgery (ESOPRS).This discourse shall feature a rapid-fire oral presentation, whereupon esteemed researchers will elucidate the efficacy, saf...
|
May 29, 2024
ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024Thyroid eye disease (TED), also known as Graves ophthalmopathy, is an autoimmune condition that affects thousands of individuals worldwide. It is characterized by inflammation and swelling in the tissues around the eyes, causing eye bulging, double vision, and even vision loss in severe cases. Patients suffering from TED often experience a significant impact on their quality of life, both physically and emotionally.In a groundbreaking development, ACELYRIN, INC. has recently announced the release of Phase 1/2 proof-of-concept data for their revolutionary drug, Lonigutamab. Lon...
|
Publicly Traded Peers of Acelyrin Inc
Amgen Inc
Share Performance
-4.17%
Over The Past 5 Days
|
Amgen Inc
Profile
Amgen Inc.s business model focuses on leveraging advanced biotechnology to create therapeutic products for various diseases, particularly in the fields of oncology, inflammation, and cardiovascular health. The company invests heavily in research and development to drive innovation, while also utilizing strategic partnerships and acquisitions to enhance its product pipeline. Additionally, Amgen emphasizes a strong global commercial presence to maximize the accessibility and impact of its therapeutics in the healthcare market.
More about Amgen Inc 's Market Share
|
Abbvie inc
Share Performance
-2.26%
Over The Past 5 Days
|
Abbvie inc
Profile
AbbVie Inc operates primarily as a global biopharmaceutical company, focusing on the research, development, manufacturing, and commercialization of advanced therapies and medications in critical areas such as immunology, oncology, neuroscience, and virology. The company aims to improve patient outcomes and address unmet medical needs by leveraging its scientific expertise and capabilities while providing value to stakeholders in the healthcare industry.
More about Abbvie inc 's Market Share
|
Gilead Sciences Inc
Share Performance
+21.29%
This Year
|
Gilead Sciences Inc
Profile
Gilead Sciences Incs business model centers on researching, developing, and marketing innovative medicines, primarily targeting antiviral therapies. They focus on addressing unmet medical needs to enhance patient health globally.
More about Gilead Sciences Inc 's Market Share
|
Vertex Pharmaceuticals Inc
Share Performance
+24.40%
This Year
|
Vertex Pharmaceuticals Inc
Profile
Vertex Pharmaceuticals Incs business model centers on the research and development of innovative therapies, primarily targeting cystic fibrosis and other serious diseases. They emphasize collaboration with organizations, strategic partnerships, and robust investment in R&D to deliver transformative treatments to patients and enhance their quality of life.
More about Vertex Pharmaceuticals Inc's Market Share
|
Regeneron Pharmaceuticals Inc
Share Performance
-30.86%
One Year
|
Regeneron Pharmaceuticals Inc
Profile
Regeneron Pharmaceuticals Inc operates a business model centered on the discovery and commercialization of cutting-edge biopharmaceuticals, particularly in the fields of ophthalmology, oncology, immunology, and rare diseases. They leverage their strong research and development capabilities, including their proprietary technologies, to create innovative therapies that address unmet medical needs. Additionally, Regeneron forms strategic collaborations and partnerships to enhance their development pipeline and expand market access for their products.
More about Regeneron Pharmaceuticals Inc 's Market Share
|
Biogen Inc
Share Performance
-7.48%
Over The Past 5 Days
|
Biogen Inc
Profile
Biogen Incs business model focuses on researching, developing, and commercializing innovative therapies primarily for neurological and neurodegenerative diseases, emphasizing advancements in precision medicine and patient care.
More about Biogen Inc 's Market Share
|
Eli Lilly And Company
Share Performance
+7.86%
One Year
|
Eli Lilly And Company
Profile
Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics.
More about Eli Lilly And Company's Market Share
|
Pfizer Inc
Share Performance
-3.45%
Over The Past 5 Days
|
Pfizer Inc
Profile
Pfizer Inc operates as a global pharmaceutical company that focuses on researching, developing, manufacturing, and marketing innovative medicines. Its business model emphasizes significant investment in research and development to build a diverse portfolio of therapies across various therapeutic areas, while leveraging strategic alliances and collaborations to enhance commercialization and drive growth.
More about Pfizer Inc's Market Share
|
Sanofi
Share Performance
+6.96%
30 Days
|
Sanofi
Profile
Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs.
More about Sanofi's Market Share
|
Merck and Co Inc
Share Performance
-5.49%
This Quarter
|
Merck and Co Inc
Profile
Merck & Co. Inc. operates primarily as a research-driven pharmaceutical company, focused on the development, manufacturing, and marketing of prescription drugs and vaccines globally. It aims to address unmet medical needs through innovative research, collaborations, and rigorous clinical trials, while promoting patient well-being and contributing to global healthcare with high-quality, affordable medications.
More about Merck and Co Inc 's Market Share
|
Johnson and Johnson
Share Performance
+3.54%
30 Days
|
Johnson and Johnson
Profile
Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.
More about Johnson and Johnson's Market Share
|
Abbott Laboratories
Share Performance
+9.72%
One Year
|
Abbott Laboratories
Profile
Abbott Laboratories operates as a diversified healthcare company with a focus on developing and manufacturing a wide range of health-related products, including pharmaceuticals, medical devices, nutritional products, and diagnostic technologies. Their business model emphasizes innovation and quality, aiming to address the diverse needs of patients and healthcare providers across various sectors globally. By leveraging their expertise and extensive portfolio, Abbott strives to enhance patient outcomes and improve the overall quality of life.
More about Abbott Laboratories's Market Share
|
Xtl Biopharmaceuticals Ltd
Share Performance
+45.45%
One Year
|
Xtl Biopharmaceuticals Ltd
Profile
Xtl Biopharmaceuticals Ltd's business model revolves around developing and commercializing innovative biopharmaceutical products.
More about Xtl Biopharmaceuticals Ltd 's Market Share
|
Bristol myers Squibb Company
Share Performance
+3.91%
This Year
|
Bristol myers Squibb Company
Profile
Bristol Myers Squibb Company operates a research and development-driven business model, focusing on the discovery and delivery of innovative medicines for various diseases. It emphasizes collaboration with academic institutions, government entities, and other pharmaceutical firms to enhance its therapeutic portfolio and improve patient outcomes.
More about Bristol myers Squibb Company's Market Share
|
Galmed Pharmaceuticals Ltd
Share Performance
-52.83%
One Year
|
Galmed Pharmaceuticals Ltd
Profile
Galmed Pharmaceuticals Ltd's business model focuses on the development and commercialization of innovative therapeutic solutions, particularly in the field of liver and metabolic diseases.
More about Galmed Pharmaceuticals Ltd 's Market Share
|
Sangui Biotech International Inc
Share Performance
0.00%
One Year
|
Sangui Biotech International Inc
Profile
Sangui Biotech International Inc's business model focuses on developing and commercializing innovative healthcare products. They aim to bring medical advancements and technological advancements together to improve patient care and outcomes. This is achieved through research, development, and the marketing of their healthcare solutions to various markets globally.
More about Sangui Biotech International Inc's Market Share
|
Actavia Life Sciences Inc
Share Performance
0.00%
Over The Past 5 Days
|
Actavia Life Sciences Inc
Profile
Rasna Therapeutics Inc is a biotechnology company that focuses on developing innovative therapies for the treatment of cancer and other diseases. Their business model revolves around leveraging cutting-edge research and technology to discover and develop novel drug candidates. They aim to partner with pharmaceutical companies or license their intellectual property to bring their therapies to market and ultimately improve patient outcomes.
More about Actavia Life Sciences Inc 's Market Share
|
Xencor Inc
Share Performance
-6.38%
Over The Past 5 Days
|
Xencor Inc
Profile
Xencor Inc is a biotechnology company that primarily focuses on the development of therapeutic antibodies. Their business model revolves around utilizing their proprietary XmAb? technology to engineer antibodies with enhanced properties for the treatment of various diseases. They collaborate with pharmaceutical companies to develop and commercialize these antibody therapeutics, generating revenue through upfront payments, milestone payments, and royalties.
More about Xencor Inc's Market Share
|
Spectrum Pharmaceuticals Inc
Share Performance
+8.65%
30 Days
|
Spectrum Pharmaceuticals Inc
Profile
Spectrum Pharmaceuticals Inc operates under a business model focused on the development, acquisition, and commercialization of oncology and hematology drugs. The company aims to bring innovative therapies to patients by leveraging its expertise in drug development, manufacturing capabilities, and commercial infrastructure. Spectrum focuses on both the internal development of new drugs as well as strategic collaborations and licensing agreements with other pharmaceutical companies.
More about Spectrum Pharmaceuticals Inc 's Market Share
|
Connect Biopharma Holdings Limited
Share Performance
-29.25%
This Year
|
Connect Biopharma Holdings Limited
Profile
Connect Biopharma Holdings Limited is a biotechnology company that develops novel therapies for inflammatory diseases by targeting the immune system. Their business model includes research and development of innovative drugs, clinical trials, and partnerships with pharmaceutical companies for commercialization.
More about Connect Biopharma Holdings Limited's Market Share
|
Lianbio
Share Performance
-81.01%
One Year
|
Lianbio
Profile
LianBio is a biopharmaceutical company that focuses on accelerating the development and commercialization of innovative medicines in the Chinese market. They collaborate with global partners to identify and acquire promising drug candidates, providing them with regulatory expertise and commercialization capabilities. By leveraging their deep understanding of the Chinese healthcare landscape, LianBio aims to bridge the gap between global innovation and Chinese patient needs.
More about Lianbio's Market Share
|
Zyversa Therapeutics Inc
Share Performance
-39.24%
30 Days
|
Zyversa Therapeutics Inc
Profile
Zyversa Therapeutics Inc's business model revolves around developing innovative therapies and treatments for various medical conditions.
More about Zyversa Therapeutics Inc 's Market Share
|
Gri Bio Inc
Share Performance
-53.64%
This Quarter
|
Gri Bio Inc
Profile
Gri Bio Inc's business model focuses on providing innovative biotechnology solutions.
More about Gri Bio Inc 's Market Share
|
Synaptogenix Inc
Share Performance
-1.81%
This Quarter
|
Synaptogenix Inc
Profile
Synaptogenix Inc is a biotechnology company focused on developing innovative therapeutics for the treatment of neurodegenerative diseases. Their business model revolves around conducting research and clinical trials to identify and develop novel drugs that target the underlying mechanisms of these diseases. By collaborating with academic institutions and utilizing their expertise, the company aims to eventually commercialize their drug candidates for the benefit of patients worldwide.
More about Synaptogenix Inc 's Market Share
|
Integrated Biopharma Inc
Share Performance
0.00%
One Year
|
Integrated Biopharma Inc
Profile
Integrated Biopharma Inc's business model can be described as a vertically integrated health and wellness company focused on producing and distributing nutritional and dietary supplements.
More about Integrated Biopharma Inc's Market Share
|
Nascent Biotech Inc
Share Performance
-82.21%
This Year
|
Nascent Biotech Inc
Profile
Nascent Biotech Inc's business model is focused on the development and commercialization of innovative therapies in the field of biotechnology. They aim to leverage their expertise and research to bring new drugs to market that can address critical unmet medical needs.
More about Nascent Biotech Inc 's Market Share
|
Evelo Biosciences Inc
Share Performance
0.00%
This Year
|
Evelo Biosciences Inc
Profile
Evelo Biosciences Inc is a biotechnology company focused on developing therapies for the treatment of various diseases. Their business model revolves around harnessing the potential of the body's own immune system through the development of monoclonal microbials. These microbials are designed to interact with the gut to elicit specific therapeutic effects, offering a novel approach to addressing medical conditions.
More about Evelo Biosciences Inc 's Market Share
|
Nexien Biopharma Inc
Share Performance
0.00%
This Quarter
|
Nexien Biopharma Inc
Profile
Nexien Biopharma Inc operates as a biotechnology company focused on the development and commercialization of innovative therapies for various medical conditions. They aim to use their expertise in biopharmaceutical research to bring novel treatments to market, improving patient outcomes and meeting unmet medical needs.
More about Nexien Biopharma Inc 's Market Share
|
Respirerx Pharmaceuticals Inc
Share Performance
0.00%
30 Days
|
Respirerx Pharmaceuticals Inc
Profile
Respirerx Pharmaceuticals Inc is a pharmaceutical company that focuses on developing and commercializing therapeutics for the treatment of respiratory diseases. Their business model centers around research, development, and marketing of innovative respiratory drugs to improve patient outcomes and address unmet medical needs in this field.
More about Respirerx Pharmaceuticals Inc 's Market Share
|
Innovation1 Biotech Inc
Share Performance
0.00%
One Year
|
Innovation1 Biotech Inc
Profile
The business model of Innovation1 Biotech Inc involves developing and commercializing innovative biotechnological products and solutions for various industries. The company focuses on research, development, and manufacturing, aiming to provide cutting-edge biotech solutions that meet the needs of diverse markets.
More about Innovation1 Biotech Inc 's Market Share
|
Dianthus Therapeutics Inc
Share Performance
-11.24%
This Quarter
|
Dianthus Therapeutics Inc
Profile
Dianthus Therapeutics Inc is a biotechnology company that focuses on developing novel genetic medicines for patients suffering from rare genetic diseases. Their business model revolves around leveraging cutting-edge gene therapy technologies to design and deliver innovative treatments. By partnering with academic institutions and utilizing a proprietary gene therapy platform, they aim to address unmet medical needs and provide potential new therapies for patients with genetic disorders.
More about Dianthus Therapeutics Inc 's Market Share
|
Aeon Biopharma inc
Share Performance
+1.77%
This Quarter
|
Aeon Biopharma inc
Profile
Aeon Biopharma Inc.'s business model focuses on the development and commercialization of biopharmaceutical products, emphasizing innovation and collaboration for the advancement of healthcare.
More about Aeon Biopharma inc 's Market Share
|
Azitra Inc
Share Performance
-18.89%
This Year
|
Azitra Inc
Profile
Azitra Inc is a company that operates on a business model focused on developing and commercializing microbiome-based therapeutics for various skin conditions. It aims to use the potential of the human skin microbiome to develop innovative and effective treatments.
More about Azitra Inc 's Market Share
|
Dmk Pharmaceuticals Corporation
Share Performance
-65.61%
This Year
|
Dmk Pharmaceuticals Corporation
Profile
DMK Pharmaceuticals Corporation has a business model focused on the development, manufacturing, and distribution of pharmaceutical products.
More about Dmk Pharmaceuticals Corporation's Market Share
|
Mereo Biopharma Group Plc
Share Performance
-9.03%
30 Days
|
Mereo Biopharma Group Plc
Profile
Mereo Biopharma Group Plc's business model focuses on the development and commercialization of innovative therapeutics for rare diseases.
More about Mereo Biopharma Group Plc's Market Share
|
Cohbar Inc
Share Performance
-45.34%
One Year
|
Cohbar Inc
Profile
Cohbar Inc is a biotechnology company that focuses on the discovery and development of peptide-based therapeutics for the treatment of age-related diseases. Their business model revolves around leveraging their proprietary peptide technology platform and partnerships with pharmaceutical companies to advance and commercialize their drug candidates.
More about Cohbar Inc 's Market Share
|
Jazz Pharmaceuticals Plc
Share Performance
+11.47%
This Year
|
Jazz Pharmaceuticals Plc
Profile
Jazz Pharmaceuticals Plc is a biopharmaceutical company focused on developing and commercializing innovative therapies for a range of medical conditions. Their business model revolves around conducting extensive research and development to identify novel molecules and compounds that can address unmet medical needs. By leveraging strategic partnerships, acquisitions, and licensing agreements, they aim to bring these therapies to market and provide valuable treatment options to patients worldwide.
More about Jazz Pharmaceuticals Plc's Market Share
|
Adhera Therapeutics Inc
Share Performance
0.00%
Over The Past 5 Days
|
Adhera Therapeutics Inc
Profile
Adhera Therapeutics Inc's business model revolves around developing and commercializing innovative medication adherence solutions. They leverage technology to provide patients with tools and support systems that help them adhere to prescribed treatments. By focusing on improving medication adherence rates, Adhera Therapeutics aims to enhance patient outcomes and reduce healthcare costs for both individuals and the healthcare industry.
More about Adhera Therapeutics Inc 's Market Share
|
Opko Health Inc
Share Performance
+20.00%
This Year
|
Opko Health Inc
Profile
Opko Health Inc is a biotechnology and pharmaceutical company that operates through various business segments. The company primarily focuses on diagnostics, developing and commercializing novel diagnostic tests for various conditions. Additionally, Opko Health engages in the production and sale of pharmaceuticals and vaccines, as well as the research and development of new medical technologies.
More about Opko Health Inc 's Market Share
|
Sarepta Therapeutics Inc
Share Performance
-2.51%
Over The Past 5 Days
|
Sarepta Therapeutics Inc
Profile
Sarepta Therapeutics Inc's business model centers around the research, development, and commercialization of innovative genetic medicines for rare diseases, with a particular focus on Duchenne muscular dystrophy (DMD).
More about Sarepta Therapeutics Inc 's Market Share
|
Biohaven Ltd
Share Performance
-30.25%
30 Days
|
Biohaven Ltd
Profile
Biohaven Ltd operates as a pharmaceutical company that focuses on discovering and developing therapies for neurological diseases and rare disorders. Their business model revolves around conducting extensive research and clinical trials to bring innovative treatments to market. By collaborating with healthcare professionals, regulatory agencies, and investors, Biohaven aims to improve the lives of patients suffering from these conditions and provide a significant return on investment for stakeholders.
More about Biohaven Ltd 's Market Share
|
Nuvation Bio Inc
Share Performance
-20.45%
This Quarter
|
Nuvation Bio Inc
Profile
Nuvation Bio Inc's business model is centered around the development of novel therapies for the treatment of cancer and other diseases.
More about Nuvation Bio Inc 's Market Share
|
Amylyx Pharmaceuticals Inc
Share Performance
+11.88%
One Year
|
Amylyx Pharmaceuticals Inc
Profile
Amylyx Pharmaceuticals Inc's business model revolves around researching, developing, and commercializing potential therapies for neurodegenerative diseases. They aim to identify promising drug candidates, conduct preclinical and clinical trials, and ultimately gain regulatory approval to market and sell their products. By focusing on innovative treatments, Amylyx Pharmaceuticals Inc aims to address unmet medical needs in the field of neurodegenerative disorders.
More about Amylyx Pharmaceuticals Inc 's Market Share
|
Lexicon Pharmaceuticals Inc
Share Performance
-85.90%
One Year
|
Lexicon Pharmaceuticals Inc
Profile
Lexicon Pharmaceuticals Inc is a biopharmaceutical company that focuses on the discovery and development of innovative drugs. Their business model revolves around identifying potential drug targets, conducting research and preclinical studies to validate these targets, and subsequently developing drugs through clinical trials for various therapeutic areas. They also collaborate with pharmaceutical companies for joint development and commercialization efforts, aiming to bring these drugs to market and improve patient outcomes.
More about Lexicon Pharmaceuticals Inc 's Market Share
|
Dice Therapeutics Inc
Share Performance
+0.36%
Over The Past 5 Days
|
Dice Therapeutics Inc
Profile
Dice Therapeutics Inc. is a biotechnology company that focuses on developing novel therapies for various diseases. Their business model revolves around leveraging innovative science and technology to identify and target disease drivers, aiming to discover and develop drug candidates that can offer substantial clinical benefits to patients. Through strategic partnerships and collaborations, they aim to bring their therapies to the market efficiently and meet the unmet medical needs in the healthcare industry.
More about Dice Therapeutics Inc 's Market Share
|
Annexon Inc
Share Performance
-0.38%
Over The Past 5 Days
|
Annexon Inc
Profile
Annexon Inc operates with a business model focused on developing therapeutic drugs to target and treat autoimmune and neurodegenerative disorders. The company conducts extensive research and preclinical studies to identify specific molecules that modulate the immune system and protect against neuroinflammation. Utilizing partnerships and collaborations, Annexon Inc aims to advance its drug candidates through clinical trials and potential commercialization to address unmet medical needs in the healthcare industry.
More about Annexon Inc 's Market Share
|
Galapagos Nv
Share Performance
-6.74%
This Year
|
Galapagos Nv
Profile
Galapagos Nv's business model is centered around the development and commercialization of innovative medicines. They leverage their expertise in drug discovery and development to collaborate with partners in the healthcare industry, focusing on the advancement of novel therapies to address unmet medical needs.
More about Galapagos Nv's Market Share
|
Abcellera Biologics Inc
Share Performance
-11.89%
This Quarter
|
Abcellera Biologics Inc
Profile
Abcellera Biologics Inc is a biotechnology company that specializes in discovering and developing therapeutic antibodies.
More about Abcellera Biologics Inc 's Market Share
|
Tiziana Life Sciences Ltd
Share Performance
+112.16%
30 Days
|
Tiziana Life Sciences Ltd
Profile
Tiziana Life Sciences Ltd's business model focuses on the development and commercialization of innovative therapeutics in the field of immunology and oncology.
More about Tiziana Life Sciences Ltd's Market Share
|
Kiniksa Pharmaceuticals International plc
Share Performance
+11.27%
This Quarter
|
Kiniksa Pharmaceuticals International plc
Profile
Kiniksa Pharmaceuticals Ltd is a biopharmaceutical company focused on developing and commercializing therapeutics for patients with debilitating diseases and unmet medical needs. Their business model revolves around identifying potential drug candidates, conducting rigorous research and development, and ultimately bringing these drugs to market to provide innovative treatment options. They generate revenue through the sale of their products and collaborations with other companies for the development and commercialization of their therapies.
More about Kiniksa Pharmaceuticals International plc's Market Share
|
Novartis Ag
Share Performance
-5.55%
Over The Past 5 Days
|
Novartis Ag
Profile
Novartis AG's business model is centered around the development, manufacturing, and marketing of innovative pharmaceutical products.
More about Novartis Ag's Market Share
|
Zymeworks Inc
Share Performance
-17.12%
This Year
|
Zymeworks Inc
Profile
Zymeworks Inc is a biotechnology company that operates on a licensing and collaboration business model. They primarily generate revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, providing access to their proprietary drug development platform and expertise in protein engineering. This enables them to advance the development of novel bi-specific antibodies and therapeutic proteins for the treatment of various diseases and medical conditions.
More about Zymeworks Inc 's Market Share
|
180 Life Sciences Corp
Share Performance
-37.79%
This Year
|
180 Life Sciences Corp
Profile
180 Life Sciences Corp is a biotechnology company engaged in the research and development of novel drugs that target inflammation and fibrosis to address various diseases such as fibrosis, inflammation, and pain.
More about 180 Life Sciences Corp's Market Share
|
Summit Therapeutics Inc
Share Performance
+15.56%
Over The Past 5 Days
|
Summit Therapeutics Inc
Profile
Summit Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of rare diseases. The company employs a research-driven business model, leveraging its proprietary technologies and expertise to identify and develop novel drugs targeting specific genetic mutations associated with these rare diseases. Summit Therapeutics Inc aims to bring its drug candidates through preclinical and clinical development stages and ultimately secure regulatory approval and commercialize them to benefit patients in need.
More about Summit Therapeutics Inc 's Market Share
|
Horizon Therapeutics Public Limited Company
Share Performance
+75.68%
One Year
|
Horizon Therapeutics Public Limited Company
Profile
Horizon Therapeutics Public Limited Company operates as a biopharmaceutical company that develops and commercializes medicines for the treatment of rare diseases. Their business model revolves around acquiring and developing innovative therapies and then distributing them to patients in need. By focusing on rare diseases with high unmet needs, Horizon Therapeutics aims to provide life-changing treatments to underserved patient populations.
More about Horizon Therapeutics Public Limited Company's Market Share
|
Royalty Pharma Plc
Share Performance
+31.08%
This Quarter
|
Royalty Pharma Plc
Profile
Royalty Pharma Plc operates as a pharmaceutical investment company, focusing on acquiring and managing royalty interests in approved drugs. Their business model primarily revolves around purchasing existing royalty streams in exchange for upfront payments, allowing them to generate ongoing cash flows from the sales of these drugs. They aim to provide liquidity to stakeholders, such as biotech and pharmaceutical companies, by offering a financial alternative to traditional financing options.
More about Royalty Pharma Plc's Market Share
|
Renovorx Inc
Share Performance
-21.14%
This Quarter
|
Renovorx Inc
Profile
Renovorx Inc is a medical technology company specializing in the development of innovative treatments for cardiovascular diseases. Their business model focuses on creating and commercializing minimally invasive therapies for patients suffering from conditions like myocardial infarction and heart failure. By leveraging cutting-edge medical devices and procedures, Renovorx aims to provide effective and efficient treatments that can significantly improve patient outcomes and quality of life.
More about Renovorx Inc 's Market Share
|
Ventyx Biosciences Inc
Share Performance
-16.07%
30 Days
|
Ventyx Biosciences Inc
Profile
Ventyx Biosciences Inc is a biotechnology company that follows a research and development-focused business model. It aims to develop innovative biopharmaceutical products and therapeutic solutions by leveraging its expertise in various fields such as genetic engineering, drug discovery, and clinical trials. The company seeks to form strategic partnerships and licensing agreements to accelerate the commercialization of its products.
More about Ventyx Biosciences Inc 's Market Share
|
Protokinetix Incorporated
Share Performance
+1.68%
30 Days
|
Protokinetix Incorporated
Profile
Protokinetix Incorporated's business model revolves around the commercialization of its proprietary technology, AAGP? (Antifreeze Protein Analog).
More about Protokinetix Incorporated's Market Share
|
Ptc Therapeutics inc
Share Performance
+84.43%
One Year
|
Ptc Therapeutics inc
Profile
PTC Therapeutics Inc's business model revolves around the research, development, and commercialization of innovative treatments for rare and genetic diseases.
More about Ptc Therapeutics inc 's Market Share
|
Hcw Biologics Inc
Share Performance
-5.35%
Over The Past 5 Days
|
Hcw Biologics Inc
Profile
HCW Biologics Inc is a biotechnology company that operates on a business model focused on the research, development, and commercialization of biologic therapies. The company primarily focuses on developing and manufacturing novel biological products for various medical conditions. Their business model involves collaboration with industry partners, conducting clinical trials, and securing regulatory approvals for the commercialization of their biologic therapies.
More about Hcw Biologics Inc 's Market Share
|
Eledon Pharmaceuticals Inc
Share Performance
-18.71%
30 Days
|
Eledon Pharmaceuticals Inc
Profile
Eledon Pharmaceuticals Inc is a pharmaceutical company that operates on a research and development model, focusing on the discovery and development of innovative drugs in various therapeutic areas. They aim to bring new drugs to market by conducting extensive research, clinical trials, and partnering with other pharmaceutical companies for manufacturing and distribution.
More about Eledon Pharmaceuticals Inc 's Market Share
|
Fortress Biotech Inc
Share Performance
-4.02%
Over The Past 5 Days
|
Fortress Biotech Inc
Profile
Fortress Biotech Inc operates as a biopharmaceutical company that acquires, develops, and commercializes novel pharmaceutical and biotechnology products. Their business model focuses on partnering with academic institutions and biotech companies to advance preclinical and clinical-stage therapies for various diseases. Additionally, they aim to leverage their expertise and partnerships to improve the development process and bring innovative treatments to patients in need.
More about Fortress Biotech Inc 's Market Share
|
Bullfrog Ai Holdings Inc
Share Performance
-56.57%
30 Days
|
Bullfrog Ai Holdings Inc
Profile
Bullfrog Ai Holdings Inc utilizes artificial intelligence technology to develop and provide advanced solutions for businesses. Their business model focuses on offering AI-powered products and services to help companies optimize their operations and decision-making processes.
More about Bullfrog Ai Holdings Inc 's Market Share
|
Palatin Technologies Inc
Share Performance
-4.84%
This Quarter
|
Palatin Technologies Inc
Profile
Palatin Technologies Inc has a business model focused on developing and commercializing innovative medicines in the field of reproductive healthcare and sexual dysfunction. The company's revenue streams primarily come from partnerships, licensing agreements, and product sales.
More about Palatin Technologies Inc 's Market Share
|
Altamira Therapeutics Ltd
Share Performance
-60.00%
This Quarter
|
Altamira Therapeutics Ltd
Profile
Altamira Therapeutics Ltd's business model revolves around developing and commercializing innovative therapeutics.
More about Altamira Therapeutics Ltd 's Market Share
|
Calcimedica Inc
Share Performance
-8.76%
Over The Past 5 Days
|
Calcimedica Inc
Profile
Calcimedica Inc is a biopharmaceutical company that focuses on the research and development of small molecule drugs to treat a range of diseases caused by calcium dysregulation. Their business model involves identifying potential drug candidates, conducting preclinical and clinical trials, and eventually commercializing these drugs to address unmet medical needs.
More about Calcimedica Inc 's Market Share
|
Xbiotech Inc
Share Performance
+3.12%
30 Days
|
Xbiotech Inc
Profile
Xbiotech Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic antibodies. They seek to address unmet medical needs by leveraging their proprietary True Human antibody technology.
More about Xbiotech Inc 's Market Share
|
Edesa Biotech Inc
Share Performance
+3.46%
Over The Past 5 Days
|
Edesa Biotech Inc
Profile
Edesa Biotech Inc's business model focuses on the development and commercialization of innovative therapeutics in the field of dermatology and gastrointestinal diseases.
More about Edesa Biotech Inc 's Market Share
|
Addex Therapeutics Ltd
Share Performance
0.00%
This Year
|
Addex Therapeutics Ltd
Profile
Addex Therapeutics Ltd operates under a business model focused on the discovery and development of novel, orally available small molecule drugs that target specific receptors in the central nervous system. The company combines its expertise in medicinal chemistry and drug development to advance its pipeline of potential therapeutics for neurological disorders.
More about Addex Therapeutics Ltd's Market Share
|
Third Harmonic Bio Inc
Share Performance
-0.58%
Over The Past 5 Days
|
Third Harmonic Bio Inc
Profile
Third Harmonic Bio Inc's business model centers around developing and commercializing innovative therapeutic solutions through the utilization of bioinformatics and genomics.
More about Third Harmonic Bio Inc 's Market Share
|
Anaptysbio Inc
Share Performance
+0.48%
This Quarter
|
Anaptysbio Inc
Profile
AnaptysBio is a biotechnology company that operates on a partnership-driven business model. They collaborate with pharmaceutical companies to develop and commercialize novel antibody therapeutics using their proprietary antibody discovery technology. By leveraging their expertise in antibody engineering and discovery, AnaptysBio aims to create innovative treatments for a wide range of diseases, including inflammation, immuno-oncology, and rare diseases.
More about Anaptysbio Inc 's Market Share
|
Cassava Sciences Inc
Share Performance
-86.90%
One Year
|
Cassava Sciences Inc
Profile
Cassava Sciences Inc is a pharmaceutical company that focuses on developing and commercializing novel drugs for neurological diseases. Their business model revolves around researching and developing innovative therapeutic solutions, conducting clinical trials to assess the effectiveness of their drugs, and ultimately marketing and selling their approved products to healthcare providers and patients. By strategically investing in the development of drugs for neurological disorders, Cassava Sciences aims to address unmet medical needs and potentially generate revenue through drug sales.
More about Cassava Sciences Inc's Market Share
|
Sage Therapeutics Inc
Share Performance
+7.52%
30 Days
|
Sage Therapeutics Inc
Profile
Sage Therapeutics Inc's business model primarily revolves around researching, developing, and commercializing innovative therapies for various central nervous system disorders. The company focuses on discovering novel molecules and applying them to create targeted treatments that address the unmet medical needs of patients. By harnessing scientific advancements and strategic collaborations, Sage aims to deliver transformative therapies for individuals suffering from conditions such as depression, postpartum depression, and other mood disorders.
More about Sage Therapeutics Inc 's Market Share
|
Prothena Corporation Public Limited Company
Share Performance
+8.96%
This Quarter
|
Prothena Corporation Public Limited Company
Profile
Prothena Corporation is a biotechnology company that focuses on developing novel therapies for diseases related to protein misfolding and amyloidosis. Their business model includes leveraging their expertise in antibody and protein engineering to develop and commercialize drug candidates, collaborating with pharmaceutical partners to advance their therapeutic programs, and continuously conducting research and development to expand their pipeline of potential treatments. Their goal is to address unmet medical needs and provide innovative solutions for patients suffering from devastating diseases.
More about Prothena Corporation Public Limited Company's Market Share
|
Structure Therapeutics Inc
Share Performance
-40.28%
One Year
|
Structure Therapeutics Inc
Profile
Structure Therapeutics Inc is a biotechnology company that utilizes a structure-based approach to develop innovative therapeutics. They focus on identifying and targeting unique protein structures to create novel drugs for various diseases.
More about Structure Therapeutics Inc 's Market Share
|
Prometheus Biosciences Inc
Share Performance
+66.60%
This Quarter
|
Prometheus Biosciences Inc
Profile
Prometheus Biosciences Inc is a biotechnology company that operates on a subscription-based business model. Their platform offers personalized diagnostic tools and services to healthcare providers, enabling them to deliver targeted treatments for patients with gastrointestinal diseases. By providing ongoing support and monitoring, Prometheus aims to improve patient outcomes and revolutionize the management of chronic conditions in the field of gastroenterology.
More about Prometheus Biosciences Inc 's Market Share
|
Belite Bio Inc
Share Performance
+0.74%
Over The Past 5 Days
|
Belite Bio Inc
Profile
Belite Bio Inc's business model involves leveraging biotechnology to develop and commercialize innovative solutions for various industries. They focus on creating sustainable and environmentally friendly products by harnessing the power of natural biological processes.
More about Belite Bio Inc's Market Share
|
Cerevel Therapeutics Holdings Inc
Share Performance
+6.52%
This Year
|
Cerevel Therapeutics Holdings Inc
Profile
Cerevel Therapeutics Holdings Inc operates as a biopharmaceutical company that focuses on developing and commercializing therapies for central nervous system disorders. Their business model revolves around innovative research and development to discover new treatments, strategic partnerships for financing and distribution, and ultimately bringing these therapies to market to improve the lives of patients with neurological conditions. They aim to address unmet medical needs in the field of neurology through their targeted drug development approach.
More about Cerevel Therapeutics Holdings Inc 's Market Share
|
Nektar Therapeutics
Share Performance
-10.32%
This Quarter
|
Nektar Therapeutics
Profile
Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs.
More about Nektar Therapeutics's Market Share
|
Mannkind Corporation
Share Performance
+16.33%
One Year
|
Mannkind Corporation
Profile
MannKind Corporation is a biopharmaceutical company that focuses on the development and commercialization of inhaled therapeutic solutions for patients with diseases such as diabetes and pulmonary arterial hypertension. The company's business model revolves around conducting research and development to create innovative inhalation therapies and gaining regulatory approvals for these treatments. They then market and distribute their products, either directly or through partnerships, to healthcare providers and patients worldwide.
More about Mannkind Corporation's Market Share
|
Arvinas Inc
Share Performance
-52.29%
30 Days
|
Arvinas Inc
Profile
Arvinas Inc's business model revolves around developing novel therapies based on protein degradation technology to address unmet medical needs.
More about Arvinas Inc 's Market Share
|
Revance Therapeutics Inc
Share Performance
-38.34%
One Year
|
Revance Therapeutics Inc
Profile
Revance Therapeutics Inc is a biotechnology company that specializes in developing innovative treatments for medical aesthetic and therapeutic applications. Their business model revolves around researching and developing novel neuromodulator products primarily for the treatment of various aesthetic and therapeutic conditions. The company aims to license or commercialize their products and technologies to generate revenue and advance patient care in collaboration with partners.
More about Revance Therapeutics Inc 's Market Share
|
Evolus Inc
Share Performance
-12.23%
30 Days
|
Evolus Inc
Profile
Evolus Inc is a pharmaceutical company that operates in the field of aesthetics, with a primary focus on developing and commercializing minimally invasive treatments for patients. Their business model revolves around researching and developing innovative neurotoxin products to address various facial aesthetic concerns. The company aims to bring their products to market through strategic partnerships with healthcare professionals and providers, ensuring widespread accessibility and utilization.
More about Evolus Inc 's Market Share
|
Morphosys Ag
Share Performance
+96.68%
This Year
|
Morphosys Ag
Profile
Morphosys Ag's business model revolves around the development and commercialization of therapeutic antibodies.
More about Morphosys Ag's Market Share
|
Puma Biotechnology Inc
Share Performance
-33.60%
One Year
|
Puma Biotechnology Inc
Profile
Puma Biotechnology Inc operates as a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for the treatment of cancer. Their business model revolves around identifying promising preclinical and clinical drug candidates, conducting rigorous research and development, and seeking regulatory approval for their products. Puma Biotechnology Inc strives to effectively market and distribute their approved therapeutics to provide patients with potentially life-saving treatment options.
More about Puma Biotechnology Inc 's Market Share
|
Innoviva Inc
Share Performance
-0.06%
This Year
|
Innoviva Inc
Profile
Innoviva Inc's business model revolves around the development and commercialization of pharmaceutical products. The company primarily focuses on creating strategic collaborations and partnerships with biopharmaceutical companies to advance innovative therapies. Innoviva generates revenue through royalty payments received based on the sales of its partnered products.
More about Innoviva Inc 's Market Share
|
Atea Pharmaceuticals Inc
Share Performance
-0.65%
This Quarter
|
Atea Pharmaceuticals Inc
Profile
Atea Pharmaceuticals Inc. is a biopharmaceutical company that focuses on developing antiviral therapeutics to combat infectious diseases. Their business model revolves around identifying and advancing novel drug candidates that target specific viral mechanisms and inhibit their replication. This includes conducting preclinical and clinical trials, engaging in strategic partnerships, and ultimately bringing effective antiviral treatments to market.
More about Atea Pharmaceuticals Inc 's Market Share
|
Myovant Sciences Ltd
Share Performance
+0.11%
Over The Past 5 Days
|
Myovant Sciences Ltd
Profile
Myovant Sciences Ltd operates under a biopharmaceutical business model primarily focused on the development and commercialization of therapies for women's health and prostate cancer. The company aims to leverage its expertise in clinical research, regulatory affairs, and manufacturing to bring innovative treatments to market and improve patients' lives. Myovant Sciences employs a combination of in-house research and development along with collaboration with strategic partners to advance its pipeline of product candidates.
More about Myovant Sciences Ltd 's Market Share
|
Medicinova Inc
Share Performance
+19.23%
One Year
|
Medicinova Inc
Profile
Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes.
More about Medicinova Inc 's Market Share
|
Biovie Inc
Share Performance
+53.13%
One Year
|
Biovie Inc
Profile
Biovie Inc is a biotechnology company that aims to develop advanced therapeutic solutions for various diseases. They have a unique business model that focuses on research and development of innovative drugs, strategic partnerships and collaborations with other organizations, along with potential commercialization of their products to generate revenue. Their goal is to create groundbreaking medical treatments that improve the quality of life for patients.
More about Biovie Inc 's Market Share
|
Vera Therapeutics Inc
Share Performance
+0.68%
Over The Past 5 Days
|
Vera Therapeutics Inc
Profile
Vera Therapeutics Inc is a pharmaceutical company that specializes in developing and commercializing innovative therapies for patients with rare and serious diseases. Their business model focuses on researching and developing novel drug candidates, conducting clinical trials, and obtaining regulatory approvals to bring their products to market. By targeting niche patient populations with unmet medical needs, they aim to provide effective treatment options and improve patient outcomes.
More about Vera Therapeutics Inc 's Market Share
|
Astria Therapeutics inc
Share Performance
-33.30%
This Quarter
|
Astria Therapeutics inc
Profile
Astria Therapeutics Inc's business model centers around developing and commercializing innovative therapeutics for various diseases and medical conditions.
More about Astria Therapeutics inc 's Market Share
|
Xilio Therapeutics Inc
Share Performance
-16.65%
This Quarter
|
Xilio Therapeutics Inc
Profile
Xilio Therapeutics Inc is a biotechnology company focused on developing and commercializing novel immunotherapies to treat cancer.
More about Xilio Therapeutics Inc 's Market Share
|
Prelude Therapeutics Inc
Share Performance
-16.31%
This Quarter
|
Prelude Therapeutics Inc
Profile
Prelude Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative small molecule therapeutic products for cancer treatment. Their business model revolves around conducting extensive research and employing a target discovery engine to identify and validate potential drug targets. By using a combination of proprietary technologies and collaborations with academic institutions, Prelude Therapeutics aims to develop and commercialize novel oncology therapies to address unmet medical needs.
More about Prelude Therapeutics Inc's Market Share
|
Eqrx Inc
Share Performance
0.00%
Over The Past 5 Days
|
Eqrx Inc
Profile
Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers.
More about Eqrx Inc 's Market Share
|
Inflarx N v
Share Performance
-55.93%
30 Days
|
Inflarx N v
Profile
Inflarx N is a company that operates on a B2B (business-to-business) model. They offer a range of services and products such as software solutions, data analytics, and consulting to businesses in the technology sector. Their revenue primarily comes from subscription fees, licensing, and consulting fees.
More about Inflarx N v 's Market Share
|
Therapeuticsmd Inc
Share Performance
-29.59%
30 Days
|
Therapeuticsmd Inc
Profile
TherapeuticsMD Inc is a pharmaceutical company that focuses on developing and commercializing innovative hormone therapy products for women. Their business model revolves around research, development, and marketing of prescription and over-the-counter products catering to women's health needs. By leveraging strategic partnerships and collaborations, they aim to bring their products to market, ultimately improving the quality of life for women.
More about Therapeuticsmd Inc's Market Share
|
Legend Biotech Corporation
Share Performance
+9.32%
Over The Past 5 Days
|
Legend Biotech Corporation
Profile
Legend Biotech Corporation is a biotech company focused on developing innovative cell therapies and gene therapies to address unmet medical needs in various diseases.
More about Legend Biotech Corporation's Market Share
|
Beigene Ltd
Share Performance
-15.85%
This Quarter
|
Beigene Ltd
Profile
BeiGene Ltd is a biotechnology company that focuses on discovering, developing, and commercializing innovative medicines to meet the needs of cancer patients in China and worldwide. They follow a vertically integrated business model, with expertise in research and development, manufacturing, and commercialization, allowing them to have control over the entire drug development process. By leveraging strategic partnerships and collaborations, BeiGene aims to bring forth cutting-edge therapies and improve treatment options for cancer patients.
More about Beigene Ltd 's Market Share
|
Organon and Co
Share Performance
+5.01%
This Quarter
|
Organon and Co
Profile
Organon and Co's business model revolves around developing and manufacturing pharmaceutical products.
More about Organon and Co 's Market Share
|
Bausch Health Companies Inc
Share Performance
-9.95%
This Year
|
Bausch Health Companies Inc
Profile
Bausch Health Companies Inc operates through three segments: Bausch + Lomb/International, Salix, and Ortho Dermatologics. The company focuses on developing, manufacturing, and marketing a wide range of pharmaceutical products, medical devices, and over-the-counter products primarily in the areas of eye health, gastroenterology, and dermatology. Bausch Health aims to provide innovative and quality healthcare solutions to improve patients' lives globally.
More about Bausch Health Companies Inc 's Market Share
|
Teva Pharmaceutical Industries Limited
Share Performance
+11.32%
Over The Past 5 Days
|
Teva Pharmaceutical Industries Limited
Profile
Teva Pharmaceutical Industries Limited is a multinational pharmaceutical company that focuses on the development, production, and marketing of generic and specialty medicines. They aim to provide affordable and accessible healthcare solutions to patients worldwide.
More about Teva Pharmaceutical Industries Limited's Market Share
|
Viatris Inc
Share Performance
-4.21%
Over The Past 5 Days
|
Viatris Inc
Profile
Viatris Inc operates as a global pharmaceutical company, specializing in the development, manufacturing, and distribution of a wide range of generic and branded medicines, as well as biosimilars.
More about Viatris Inc 's Market Share
|
Astrazeneca Plc
Share Performance
+2.12%
Over The Past 5 Days
|
Astrazeneca Plc
Profile
AstraZeneca Plc is a global biopharmaceutical company focused on the research, development, and commercialization of innovative medicines. Their business model involves investing extensively in research and development to discover novel treatments for a wide range of diseases. AstraZeneca then markets and sells these medicines globally, collaborating with healthcare providers and leveraging their strong sales and distribution networks.
More about Astrazeneca Plc's Market Share
|
Medicure Inc
Share Performance
0.00%
This Quarter
|
Medicure Inc
Profile
Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.
More about Medicure Inc 's Market Share
|
Aptinyx Inc
Share Performance
+51.18%
30 Days
|
Aptinyx Inc
Profile
Aptinyx Inc's business model involves developing and commercializing novel therapies for brain and nervous system disorders. They focus on utilizing their proprietary chemistry platform to discover and develop small molecule therapies that target specific receptors, with an aim to address the unmet medical needs in central nervous system disorders.
More about Aptinyx Inc 's Market Share
|
Timber Pharmaceuticals Inc
Share Performance
-74.24%
One Year
|
Timber Pharmaceuticals Inc
Profile
Timber Pharmaceuticals Inc is a pharmaceutical company that operates on a business model centered around the research and development of innovative therapeutics. They focus on identifying and advancing novel treatments for various dermatological conditions. By leveraging their expertise in drug development, Timber Pharmaceuticals aims to bring safe and effective medications to market to address the unmet needs in dermatology.
More about Timber Pharmaceuticals Inc 's Market Share
|
Allarity Therapeutics Inc
Share Performance
-2.18%
30 Days
|
Allarity Therapeutics Inc
Profile
Allarity Therapeutics Inc is a biotechnology company that leverages its unique drug response profiling platform to develop personalized cancer treatments. They use AI algorithms to match patients with the most effective therapies by analyzing their individual molecular profiles.
More about Allarity Therapeutics Inc 's Market Share
|
Viracta Therapeutics Inc
Share Performance
-87.74%
This Quarter
|
Viracta Therapeutics Inc
Profile
Viracta Therapeutics Inc is a biopharmaceutical company focused on developing targeted therapies for viral-associated cancers. The company aims to advance research, develop innovative treatments, and commercialize products to improve the lives of patients suffering from these types of cancers.
More about Viracta Therapeutics Inc 's Market Share
|
Biophytis Sa
Share Performance
-38.51%
30 Days
|
Biophytis Sa
Profile
Biophytis SA is a biotechnology company that focuses on developing innovative therapeutics for age-related diseases, with a specific emphasis on degenerative eye diseases and muscle wasting conditions. They leverage their expertise in biology and clinical development to discover and advance targeted drug candidates, aiming to address the unmet medical needs of patients in these areas.
More about Biophytis Sa's Market Share
|
Galecto Inc
Share Performance
-80.19%
One Year
|
Galecto Inc
Profile
Galecto Inc operates on a business model that focuses on developing novel therapeutics based on galectin inhibitors, targeting fibrosis and inflammation-related diseases. The company aims to bring these innovative drugs to market by leveraging their expertise in drug discovery and development, while forming strategic partnerships and collaborations within the pharmaceutical industry.
More about Galecto Inc 's Market Share
|
Protagenic Therapeutics Inc new
Share Performance
-5.11%
Over The Past 5 Days
|
Protagenic Therapeutics Inc new
Profile
Protagenic Therapeutics Inc has developed a novel business model focused on the discovery and development of novel therapeutics targeting the PGRMC1 receptor, which plays a crucial role in various diseases. By leveraging their proprietary technology and partnerships, the company aims to advance the development of innovative drugs that can effectively treat a range of conditions influenced by the PGRMC1 receptor.
More about Protagenic Therapeutics Inc new's Market Share
|
Satsuma Pharmaceuticals Inc
Share Performance
+2.80%
30 Days
|
Satsuma Pharmaceuticals Inc
Profile
Satsuma Pharmaceuticals Inc's business model focuses on the development and commercialization of therapeutics for the treatment of migraine.
More about Satsuma Pharmaceuticals Inc 's Market Share
|
Nanoviricides inc
Share Performance
+2.50%
One Year
|
Nanoviricides inc
Profile
Nanoviricides Inc. is a pharmaceutical company that operates on a business model based on the development and commercialization of nanomedicines.
More about Nanoviricides inc 's Market Share
|
Immuron Limited
Share Performance
+2.25%
Over The Past 5 Days
|
Immuron Limited
Profile
Immuron Limited's business model involves the development and commercialization of oral immunotherapeutics that target and treat various diseases.
More about Immuron Limited's Market Share
|
Iterum Therapeutics Plc
Share Performance
+5.34%
Over The Past 5 Days
|
Iterum Therapeutics Plc
Profile
Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market.
More about Iterum Therapeutics Plc's Market Share
|
Aquestive Therapeutics Inc
Share Performance
+11.81%
Over The Past 5 Days
|
Aquestive Therapeutics Inc
Profile
Aquestive Therapeutics Inc follows a business model that focuses on the development and commercialization of innovative products to address unmet medical needs. The company primarily operates in the pharmaceutical industry, leveraging its proprietary drug delivery technology to create and improve various medications for patients.
More about Aquestive Therapeutics Inc 's Market Share
|
Esperion Therapeutics inc
Share Performance
-5.06%
Over The Past 5 Days
|
Esperion Therapeutics inc
Profile
Esperion Therapeutics Inc's business model focuses on the development and commercialization of innovative therapies for addressing cardiovascular diseases.
More about Esperion Therapeutics inc 's Market Share
|
Cellectar Biosciences inc
Share Performance
+12.31%
30 Days
|
Cellectar Biosciences inc
Profile
Cellectar Biosciences Inc is a biopharmaceutical company that focuses on the development of targeted cancer therapies. They utilize their proprietary drug conjugation platform to create targeted small molecules that can selectively bind and deliver radioactive isotopes directly to cancer cells. Their business model revolves around developing and commercializing these innovative therapies for the treatment of various types of cancer, aiming to improve patient outcomes and potentially revolutionize cancer treatment.
More about Cellectar Biosciences inc 's Market Share
|
Journey Medical Corp
Share Performance
+6.92%
This Quarter
|
Journey Medical Corp
Profile
Journey Medical Corporation is a pharmaceutical and medical device company that specializes in developing and commercializing innovative products for dermatology and aesthetics. Their business model revolves around conducting research and development to create new products, acquiring the necessary regulatory approvals, and partnering with healthcare professionals to effectively distribute and market these products. By focusing on dermatology and aesthetics, Journey Medical Corporation aims to address unmet medical needs and provide cutting-edge solutions to improve patient outcomes in these fields.
More about Journey Medical Corp's Market Share
|
Casi Pharmaceuticals inc
Share Performance
-14.09%
30 Days
|
Casi Pharmaceuticals inc
Profile
Casi Pharmaceuticals Inc. operates under a business model that focuses on the development and commercialization of innovative pharmaceutical products. They likely employ a combination of in-house research and development, partnerships, and licensing agreements to bring their products to market. The company may also engage in strategic marketing and distribution partnerships to ensure the successful commercialization of their therapeutics.
More about Casi Pharmaceuticals inc 's Market Share
|
Mineralys Therapeutics Inc
Share Performance
+39.71%
30 Days
|
Mineralys Therapeutics Inc
Profile
Mineralys Therapeutics Inc is a biotechnology company that follows the business model of developing and commercializing novel therapeutics for various diseases. They focus on discovering and advancing small molecule drugs based on innovative research approaches. Their business model is centered around conducting preclinical and clinical trials, obtaining regulatory approvals, and ultimately bringing their therapeutic products to market for improved patient outcomes.
More about Mineralys Therapeutics Inc 's Market Share
|
Takeda Pharmaceutical Company Limited
Share Performance
+3.73%
One Year
|
Takeda Pharmaceutical Company Limited
Profile
Takeda Pharmaceutical Company Limited operates under a business model that primarily focuses on research, development, and commercialization of innovative pharmaceutical products. They collaborate with various stakeholders across the healthcare industry, including academia, biotechnology companies, and patient advocacy groups, to drive scientific advancements and understand patient needs. By leveraging their expertise, global presence, and strategic partnerships, Takeda aims to make a positive impact on patients' lives while ensuring long-term growth and sustainability.
More about Takeda Pharmaceutical Company Limited's Market Share
|
Bicycle Therapeutics Plc
Share Performance
-22.42%
30 Days
|
Bicycle Therapeutics Plc
Profile
Bicycle Therapeutics Plc's business model is centered around the development and commercialization of novel therapeutics using its proprietary bicyclic peptide platform.
More about Bicycle Therapeutics Plc's Market Share
|
Mirati Therapeutics Inc
Share Performance
-0.14%
30 Days
|
Mirati Therapeutics Inc
Profile
Mirati Therapeutics Inc is a biotechnology company that focuses on the research, discovery, and development of precision oncology treatments for patients with cancer. Their business model involves leveraging their proprietary drug discovery platform to identify and develop targeted therapies, and collaborating with partners for the commercialization of their products.
More about Mirati Therapeutics Inc 's Market Share
|
Infinity Pharmaceuticals Inc
Share Performance
-91.21%
30 Days
|
Infinity Pharmaceuticals Inc
Profile
Infinity Pharmaceuticals Inc's business model revolves around the discovery, development, and commercialization of innovative therapies for the treatment of challenging diseases, primarily in the field of oncology.
More about Infinity Pharmaceuticals Inc 's Market Share
|
Moonlake Immunotherapeutics
Share Performance
-18.41%
One Year
|
Moonlake Immunotherapeutics
Profile
Moonlake Immunotherapeutics's business model revolves around the development and commercialization of innovative immunotherapies for the treatment of diseases.
More about Moonlake Immunotherapeutics's Market Share
|
Viridian Therapeutics Inc
Share Performance
-19.43%
This Year
|
Viridian Therapeutics Inc
Profile
Viridian Therapeutics Inc is a biotechnology company that focuses on developing novel therapeutics to treat various diseases.
More about Viridian Therapeutics Inc 's Market Share
|
Sources: Acelyrin Inc and all companies mentioned above in this report
|
